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Association between blood pressure and the rate of decline in renal
function with age. A significant negative correlation (P < 0.000 1) exists
between the mean blood pressure (MBP) and the rate of decline in
creatinine clearance with time in years (Br) in 446 subjects in the
Baltimore Longitudinal Study on Aging (BLSA) followed serially on
five or more visits over a period of 8 or more years. Even when the 118
subjects with possible renal and/or urinary tract pathology (category I)
and 74 subjects treated with diuretic and/or antihypertensive agents
(category 2) were not included, this relationship remained in the 254
"normal" (category 3) subjects. Since both MBP and negativity of the
Bc, tend to increase with age, multiple regression analyses using both
MBP and age as independent variables were performed to determine
their respective influences on Bcr. Both MBP and age significantly
influenced Bcr. When those subjects with hypertension (mean MBP >
107 mm Hg) were not included, however, the inverse relationship
between MBP and B. is lost, suggesting that an accelerated loss of
renal function is observed primarily because of the impact exerted by
individuals with blood pressures in the hypertensive range.
Association entre Ia pression sanguine et Ia vitesse de déclin de Ia
fonction rénale avec l'age. Une correlation negative significative (P <
0,0001) existe entre Ia pression sanguine moyenne (MBP) et Ia vitesse
de déclin de Ia clearance de Ia créatinine avec le temps en années (Bcr)
chez 446 sujets de la Baltimore Longitudinal Study on Aging (BLSA)
suivis sequentiellement par cinq visites ou plus sur une periode de 8 ans
ou plus. Même quand les 118 sujets atteints d'une pathologie possible
du rein et/ou du tractus urinaire (catégorie 1) et les 74 sujets traItés par
des agents diuretiques et/ou antihypertenseurs (catégorie 2) n'ont pas
été inclus, cette relation a persisté chez les 254 sujets "normaux"
(catégorie 3). Puisque MBP comme Ia négativith de Bc. tendent a
augmenter avec l'hge, des analyses par regressions multiples en utilis-
ant MBP et l'hge comme variables indépendantes ont été effectuées
pour determiner leur influence respective sur Bcr. MBP et l'âge
influencaient significativement Bcr. Cependant quand les malades at-
teints d'hypertension (MBP moyenne> 107 m Hg) n'htaient pas inclus,
Ia relation inverse entre MBP et Bc, était perdue, cc qui suggère qu'une
perte accélCrhe de fonction rénale s'observe essentiellement en raison
de I'impact exercé par les individus ayant des pressions sanguines dans
des zones hypertendues.
Glomerular filtration rate (GFR), as estimated by the clear-
ance of inulin, urea and creatinine, has been shown to decline
with age after maturity in a number of cross-sectional studies
[1—3]. The first study to show a similar decline in creatinine
clearance with age in a longitudinal study was reported from the
Baltimore Longitudinal Study on Aging (BLSA) [4, 51.
One variable recognized to affect the rate of decline of renal
function over time is blood pressure (BP) [6—8]. Individuals with
moderate to severe hypertension exhibit a progressive loss in
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renal function and often succumb to the azotemia of arteriolar
nephrosclerosis. Whether or not individuals with milder hyper-
tension also have an accelerated loss of renal function with age
remains less well defined.
The present study is designed to evaluate the influence of BP
on the rate of decline in renal function (creatinine clearance)
with age. The 446 subjects in the BLSA with creatinine clear-
ances obtained on five or more visits were selected for study
recognizing that it would require at least this many data points
from each subject to obtain a meaningful linear regression line
for individual subjects.
Methods
Subjects. The 446 participants in the Baltimore Longitudinal
Study of Aging (BLSA) with five or more serial creatinine
clearance determinations obtained between 1958 and 1981 were
included in this study. Up to 14 studies were performed in
individual subjects. The subjects were selected from 1015
community-dwelling volunteers ranging from 22 to 97 years at
entry into the study. These men spent 2.5 days in the Gerontol-
ogy Research Center (GRC) at 12- or 18-month intervals under-
going a battery of clinical, physiologic, and psychologic tests
(subjects over age 65 were seen every 12 months). Subjects
were predominantly white, generally of the middle and upper
socioeconomic status, and involved in sedentary work. All
participants in the longitudinal study were self-recruited. Social
and demographic characteristics of the study population have
been described in greater detail elsewhere [9].
Creatinine clearance determinations. A nonfasting serum
sample for creatinine determinations was obtained on arrival at
the GRC (9 to 11 A.M.) and a 24-hr urine collection then was
begun. A fasting serum sample for creatinine also was obtained
at 8:00 AM, the next morning, and the mean of the two
determinations was used in the calculation of creatinine clear-
ance. True creatinine concentrations in serum and urine were
measured using a modification of the technique of Hare [10].
Acid tungstate filtrates of serum were treated with Lloyd's
reagent and acid picrate buffer to remove non-creatinine
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chromagens. Creatinine then was eluted from the Lloyd's
reagent with alkaline picrate and measured colorimetrically.
Recovery of creatinine added to serum was 100 1.7% (SD).
There were no changes in creatinine methodology during the
period of the study reported. Creatinine clearance determina-
tions were performed on all visits from 1958 to 1974. After that,
the test was performed only on visits 1, 2, and 5 and every
fourth visit thereafter.
Blood pressure determinations. A single resting supine BP
reading is obtained from all subjects by a physician within 1 to
3 hr after admission to the GRC as part of a complete history
and physical examination. Systolic and diastolic pressures are
recorded and a mean blood pressure (MAP) computed as the
diastolic pressure plus one-third the difference between the
systolic and diastolic pressures.
Subject classification. The medical records of the 446 sub-
jects with five or more creatinine clearances are stored in the
computer facilities of the GRC. To define a "normal" or
"clinically clean" group for the study of the effects of BP and
age on creatinine clearance, subjects were divided into three
categories based on the following criteria:
Category 1. Subjects with evidence suggesting potential renal
or urinary tract disease
• Any subject who gave a history of urinary tract infection
(cystitis, pyelonephritis, and so forth), hematuria, or protein-
uria.
• Any subject who, on any visit, showed white or red blood
cells greater than 10 per high power field, casts greater than 6
per low power field, or greater than 1 + proteinuria.
• Any subject with a history or evidence of renal stones.
• Any subject with a history of glomerulonephritis, renal
surgery, acute renal failure, or other potentially significant renal
disease.
• Any subject with a history or evidence of significant
urinary retention and/or obstructive lesions (patients with be-
nign prostatic hypertrophy and/or cancer of the prostate with or
without prostatectomy or transurethral resection of the prostate
were considered normal unless other urinary tract pathology
was present).
Category 2. Subjects with hypertension and/or edematous
disorders
These subjects were those treated at any time during the
study with diuretics and/or antihypertensive agents; they were
placed in category 2 but had no renal or urinary tract pathology
which would have placed them preferentially in category 1.
Category 3. Normal subjects
Those subjects without evidence of renal or urinary tract
pathology as mentioned in category 1 and who did not receive
diuretics or antihypertensive agents during the course of their
study (category 2) were placed in category 3.
Data management system
The data management system of the BLSA provides collec-
tion, storage, and analysis of a variety of physiological, psycho-
logical, biochemical, medical, sociological, nutritional, and
body composition measurements. The data base is comprised of
records in fixed-field formats including numerically encoded
data from histories and physical examinations and laboratory
results. All medical diagnoses also are recorded on each visit.
Subsets of data from this data base system were extracted in
forms suitable for analysis by Systematic Analysis Systems
(SAS) programs and specific programs developed for the
BLSA. The initial printout plotted individual creatinine clear-
ances and components of BP (systolic, diastolic, and mean)
against both date of study and age of subject at the time of each
study. Linear regression lines for individual subjects were
plotted from the creatinine clearance and BP data versus time
and age in years. Each subject was characterized by his mean
age over the entire period of study, and placed into the
appropriate decade group.
A general linear model (GLM) computer program was uti-
lized for simple linear regression and correlation analysis in-
cluding analysis of variance of the regression to determine the
effects of mean blood pressure (MBP) on the slope of the
creatinine clearance determinations plotted against time in
years (Bcr). A model is fitted to the formula Y = a + bx, where
Y = Bcr, a is the Y intercept, x is the MBP, and b is the slope
(regression coefficient) of the MBP against time in years (BMBP).
The effect of the independent variable MBP on the dependent
variable Bcr was tested for each category of subject and age
group and for all combinations. A Student's t test is used to test
the probability that the slope of the regression equation (regres-
sion coefficient) is equal to zero (null hypothesis).
The quadratic regression equation, Y = a + bx + cx2, also
was tested to determine if this would improve the fit of the data.
One might anticipate that a higher MBP might accelerate
deterioration of renal function (the negative slope of the cre-
atinine clearance with time in years) making a curvalinear
regression line a more appropriate fit. Finally, a program for
multiple regression and correlation analysis including analysis
of variance of the regression was utilized to determine the
relative impact of MBP and age as independent variables on
Bcr. A model is fitted to the formula, Y = a + bx1 + cx2, where
Y = the rate of change of creatinine clearance (Bar), a is a Y
intercept, x1 is MBP, x2 is the age in years and b and c are their
respective regression coefficients.
Results
Subject categorization
One might anticipate that subjects with renal and/or urinary
tract disease might introduce a bias into this study by the
association of increased BP and accelerated decline in renal
function as the kidney can be either causal or a target organ in
hypertension. Therefore, subjects with any history or evidence
of renal and/or urinary tract disease were separated into cat-
egory 1. Of similar concern were the subjects who received
diuretic and/or antihypertensive agents at some time during the
course of their study, so they were placed in category 2. The
remaining subjects were considered "normal" and were placed
in category 3.
There were 118 subjects placed in category 1 for 152 reasons
because many subjects had more than one indication of renal
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Table 1. Cross-sectional tabulation of mean SEM creatinine clearances and systolic, diastolic, and mean blood pressures by age decades (446
subjects with 5 or more observations)
Mean age
No.
subjects
Creatinine
clearances
cc/mm
Systolic blood
pressures
Diastolic blood
pressures
Mean blood
pressures
mm Hg
20 to 29.9 3 151.8 15.7 125.6 6.5 81.9 3.1 96.5 4.1
30 to 39.9 36 154.8 3.6 123.1 2.0 80.9 1.4 95.0 1.6
40 to 49.9 104 144.4 2.1 124.4 1.1 81.5 0.9 95.8 0.9
50 to 59.9 122 134.3 1.7 130.5 1.3 83.7 0.8 99.3 0.9
60 to 69.9 86 122.3 2.5 137.4 1.6 83.0 0.9 101.2 1.1
70 to 79.9 81 107.0 2.4 141.2 2.0 82.6 1.0 102.1 1.3
80 to 89.9 13 91.9 0.6 140.2 4.5 80.7 2.0 100.5 2.8
90 to 99.9 1 32.0 150.0 76.0 100.7
Table 2. Mean SEM creatinine clearance and systolic, diastolic, and mean blood pressures and regression coefficients of these determinations
as influenced by time (years) in the study in subjects with renal and urinary tract abnormalities (category 1), subjects treated with diuretics and/
or antihypertensive agents (category 2), and "normal" subjects (category 3)
Variables Category 1 Category 2 Category 3
No. subjects 118 74 254
Age 59.2 1.1 57.3 1.5 56.4 0.8
Creatinine clearance, cc/mm 125.8 2.33 135.2 3.40 129.9 1.69
Bar, cc/mm/year —1.10 0.23 —0.92 0.32 —0.75 0.12
Systolic BP, mm Hg 133.0 1.42 143.1 1.64 128.4 0.95
BSBP, mm Hg/year 0.29 0.16 0.55 0.21 0.65 0.11
Diastolic BP, mm Hg 83.6 0.83 89.7 0.84 79.9 0.46
BDBP, mm Hg/year 0.09 0.08 0.22 0.13 0.25 0.06
Mean BP, mm Hg 100.1 1.0 107.5 1.0 96.1 0.6
BMBP, mm Hg/year 0.16 0.09 0.33 0.14 0.38 0.07
Abbreviations: Bc,., regression coefficient of the creatinine clearance determinations plotted against time in years; BSBP, regression coefficient of
the systolic blood pressure against time in years; BDBP, regression coefficient of the diastolic blood pressure against time in years; BMBP, regression
coefficient of the mean blood pressure against time in years.
and/or urinary tract pathology. There were 58 subjects who
gave a history of urinary tract infection with 15 specifying
pyelonephritis, 18 cystitis, and 25who could not specify the site
of infection. There were three subjects with a history of
proteinuria and ten with a history of hematuria. There were 19
subjects who had significant urinary findings during one or more
of their visits with 12 showing pyuria, 4 hematuria, 2 protein-
uria, and I cylinduria. Forty-six subjects had a history or
evidence of renal stone disease.
Ten subjects had a history of other significant renal pathol-
ogy, including acute glomerulonephritis (1), acute renal failure
(1), arteriolar nephrosclerosis (3), perirenal abscess (1),
nephrectomy for tumor (1), and renal cysts (4) with one
surgically removed. The other five subjects had a history of
retention and/or obstructive lesions that were considered po-
tentially significant in severity and/or duration.
A conservative approach was taken to eliminate subjects with
potential renal and/or urinary tract pathology. Actually, only 8
of the 118 category 1 subjects had clearly definable renal lesions
and deteriorating renal function (decline in creatinine clearance
greater than 2.8 cc/mm/year; mean, 4.9 cc/mm/year) which
would clearly separate them from the "normal" (category 3)
subjects. Three exhibited arteriolar nephrosclerosis, four
chronic pyelonephritis, and one had a left nephrectomy for
tumor.
An additional 74 subjects were started on diuretic and/or
antihypertensive agents (category 2) during the course of the
study. Of these, 23 were started on these treatments after five or
more visits during which clearances were performed. One might
reason that the data obtained from these subjects prior to
initiating therapy could and should be added to the category 3
group as they would have been considered normal up to the
time the medications were first administered. Furthermore,
because this group might be anticipated to have higher MBPs
and more rapid declines in creatinine clearances, their data
were compared to those observed in category 3 subjects to see
if any bias might be introduced or if a significant subgroup might
be missed if their data were not added to the category 3 group.
The category 2 subgroup was younger than the category 3
group (48.1 2.1 vs. 56.4 0.8 years), had higher mea
creatinine clearances (150.5 5.1 vs. 129.9 1.7 cc/mm), and
a less rapid decline in creatinine clearances with age (—0.38
0.48 vs. —0.75 0.12 cc/min/yr) using only that data collected
prior to beginning the first medication. The difference in mean
ages of the two groups explains the differences in Bcr. The mean
systolic, diastolic, and mean blood pressures were higher (MBP
102.4 1.3 vs. 96.1 0.6mm Hg), as would be expected, and
slopes of the increases in pressures with time were greater (1.37
0.27 vs. 0.38 0.07 mm Hg/year). Failure to add this
subgroup of category 2 subjects to category 3 subjects de-
creases the sample size less than 10% and would not appear to
create a bias. Furthermore, there did not appear to be any
changes in Bc. introduced by initiation of antihypertensive or
diuretic therapies.
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Table 3. Mean SEM creatinine clearances, regression coefficients of creatinine clearances versus time (year) (Bar) and mean BP by age
decades and categorya
Age integer 30 to 39.9 40 to 49.9 50 to 59.9 60 to 69.9 70 to 79.9 80 to 89.9
Category 1
No. subjects
Creatinine clearance, cc/mm
Bcr, cc/mm/yr
Mean BP, mm Hg
Category 2
No. subjects
Creatinine clearance, cc/mm
Bcr, cc/mm/yr
Mean BP, mm Hg
Category 3
No. subjects
Creatinine clearance, cc/mm
BCR, cc/mm/yr
Mean BP, mm Hg
All subjects
No. subjects
Creatinine clearance, cc/mm
Bar, cc/mm/yr
Mean BP, mm Hg
9
146.4 4.6
—0.04 0.84
94.8 3.5
4
165.7 11.6
+0.36 0.63
105.6 5.6
23
152.6 4.8
+0.67 0.36
93.2 1.6
36
154.8 3.6
+0.46 0.31
95.8 1.6
17
138.0 4.4
+0.13 0.61
97.7 2.5
18
157.8 4.8
—0.92 0.49
105.2 1.7
69
142.5 2.6
0.32 0.19
92.9 0.9
104
144.4 2.1
—0.35 0.18
95.8 0
41
131.4 3.3
—0.72 0.29
101.9 1.7
20
135.1 4.6
—1.00 0.61
107.2 2.1
61
136.0 2.2
0.57 0.20
94.9 1.0
122
134.3 1.7
—0.69 0.17
99.3 0.9
23
122.2 6.1
—2.23 0.66
101.6 2.3
17
131.0 5.1
—0.80 0.43
109.1 2.3
46
119.2 3.1
1.24 0.28
98.0 1.1
86
122.3 2.5
—1.42 0.25
101.2 1.1
23
108.8 4.3
—1.84 0.49
99.3 2.2
12
104.7 6.1
—0.77 1.32
111.0 2.1
46
106.7 3.3
1.49 0.30
101.2 1.7
81
107.0 2.4
—1.48 0.29
102.1 1.3
5
96.9
—1.51
98.9
2
72.2
2.77
102.8
6
94.2
3.25
101.1
13
91.9
—2.50
100.5
13.4
0.57
2.3
2.2
0.80
4.3
5.9
0.70
5.8
6.0
0.45
2.8
The table excludes four subjects in the 3rd and 10th age decades.
Cross-sectional studies
Table 1 provides a cross-sectional analysis of the mean
creatinine clearances and systolic, diastolic, and mean blood
pressures for all 446 subjects with five or more determinations.
Each subject is included in an age group determined by the
mean of all his ages to the nearest 0.1 year at the time of each
visit to the GRC. Each subject has a single mean value and
standard error of the mean (sEM) calculated from all studies
performed. Mean and SEM for each age group then are calcu-
lated using this single mean SEM value for each determination
in each subject.
These data show, as has been reported previously [4, 5], the
rate of decline in creatinine clearance becomes greater with
increasing age. The mean cross-sectional change of —0.87
cc/mm/year for all subjects matches very closely that reported
by other investigators [1—3]. The systolic and diastolic blood
pressures both increase with age; the former increases more
rapidly. These relationships hold true when the subjects are
separated into three diagnostic categories.
Longitudinal analyses
Table 2 shows the mean SEM ages, creatinine clearances,
and systolic, diastolic, and mean blood pressures for each of the
three categories. The slopes of the regression equations (regres-
sion coefficients) for each of these determinations also are
shown. The mean creatinine clearances are nearly identical in
categories 1 and 3 subjects if one corrects for age differences in
the populations under study. The higher clearances in category
2 subjects do not reach levels of statistical significance. Cat-
egories I and 2 subjects also have more rapid declines in
creatinine clearances with time in years (Bar) than do category
3 subjects, but again, these differences do not reach levels of
statistical significance. The systolic pressure increases more
with time than does the diastolic pressure with the calculated
mean pressure being intermediate.
Table 3 shows selected information from Table 2 with separa-
tion into age decades (the data from four subjects in the 20 and
90 age decades have been excluded because of the small
number of subjects). The rate of decline in renal function
increases with age in all diagnostic categories and in all sub-
jects. Furthermore, the MBPs increase with age in each of these
groups. Since the creatinine clearances decrease more rapidly
and MBPs are increased in older subjects, the influence of age
on both variables must be considered.
Correlation of the rate of decline in renal function with MBP
Table 4 shows the results of comparing the slope (regression
coefficient) of Br as the dependent variable against MBP as the
independent variable using simple linear regression equations
and correlations. The study population is broken down by age
decade and diagnostic category. When the Bc. is compared
against the MBP in all 446 subjects with five or more determina-
tions, renal function decreases significantly more rapidly as
MBP increases (r 0.24, P < 0.0001). The regression co-
efficient of —0.052 (P < 0.0001) means that for each 1 mm
increase in MBP, the Br decreases by 0.052 cc/mm/year under
study. The decrease over a 10-year period would be 0.52
cc/mm/mm Hg increase so that a subject with a 110 mm Hg
MBP would be expected to have associated a 5.2 cc/mm greater
decline in creatinine clearance over a 10-year period than a
similar subject with a 100 mm Hg MBP.
Because of the important influence of age on both variables in
this relationship, the data are displayed by age decade and
diagnostic category in Table 4. When one examines all subjects
in each category, there are highly significant (P < 0.001)
negative correlations between Bcr and MBP in categories I and
3, but not in category 2 although the slope is comparable (Figs.
1 to 3). When subjects are grouped by age decade but not
separated by diagnostic category, three of six decades have
statistically significant negative correlations (P < 0.05). When
30 to 39.9
40 to 49.9
50 to 59.9
60 to 69.9
70 to 79.9
80 to 89.9
6
SE 4
0)0
2
0
0)H -
°oi —6C>°
-80)(00
10
12
36 —0.039 0.034
104 —0.053 0.019c
122 —0.039 0.017b
86 —0.026 0.026
81 —0.051 0.0250
13 —0.003 0.049
No. B SE0
9 —0.106 0.081
17 —0.111 0.057
41 —0.005 0.028
23 —0.069 0.061
23 —1.53 0.035d
5 —0.189 0.091
80 85 90 95 100 105 110 115 120 125 130
Mean blood pressure, mm Hg
Fig. 1. Regression coefficients (RC) plotting decline in renal function
(change in creatinine clearance i> . time in years or Bcr) against mean
blood pi essure (MBP): Category 1, 118 subjects with possible underly-
ing renal and/or urinary trast disease.
Category 2
No. B SEES No.
4 —0.072 0.062 23
18 —0.042 0.070 69
20 —0.127 0.063 61
17 —0.053 0.046 46
12 —0.273 0.176 46
2 +0.186 6
B SEbSt
+0.011 0.049
—0.040 0.024
—0.046 0.027
—0.059 0.036
—0.013 0.027
+0.029 0.058
254 —0.048 0.013d
data are further separated by age decade and diagnostic cat-
egory, the same trends remain but the numbers of subjects
become sufficiently small so that it is difficult to demonstrate
statistical significance. One can conclude from this table that
some negative correlation between B. and MBP exists even
after correction for age.
One additional hypothesis tested was that the more rapid
decline in creatinine clearance with time was due principally to
those subjects with the highest MBP. The specific question was
posed as to whether or not the rate of decline in creatinine
clearance was affected by MBP within the normal range.
Subjects with mean MBP above 120 mm Hg (equivalent to
160/100 mm Hg) first were eliminated from the study population
and the computations were repeated. Sequential cuts were
made to exclude subjects with MBPs above 114 mm Hg
(equivalent to 150/95 mm Hg) and 107 mm Hg (equivalent to
140/90 mm Hg). The total group and categories 1 and 3
continued to have significant negative correlations between Bc.
and MBP at the 120 and 114 mm Hg cuts (Table 5). When the
Br was compared against the MBP in the various decades and
by category, the same trends persisted, especially in category 3,
but the negative correlation generally lost its statistical signifi-
cance. At the 107 mm Hg cut, the significant negative correla-
tion no longer existed.
Correlation of the rate of decline in creatinine clearance with
MBP and age
Table 6 shows the multiple regression and correlation analy-
sis including analysis of variance of the regression to determine
the relative effects of the two independent variables MBP and
age on the dependent variable B. in all subjects and category 3
subjects. In both groups, both MBP and age had statistically
significant effects on the Br as seen by testing each of the
partial regression coefficients using a Student's t test, by testing
the sum of squares for each variable using an F test, and by
testing the significance of the correlation coefficient (r) using a
Student's t test.
When one uses the same multiple regression and correlation
analysis on all subjects and category 3 subjects alone excluding
subjects stepwise with MBPs above 120, 114, and 107 mm Hg
(Table 6), the MBP is a significant variable at MBP less than 120
and 114 mm Hg. At the MBP less than the 107 mm Hg cutoff,
most of the effect of the MBP on the Bc[ is lost, again suggesting
Blood pressure and creatinine clearance
Age decade No.
All subjects Category I
B SEES(
Table 4. Regression coefficient (B) SE of the Estimates (SEE) using Bcr as the dependent variable and MBP as the independent variable by
age decade and by category [Model (Bc. = a + b MBP)Ia
Category 3
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All ages 446 —0.052 0.010° 118 —0.076 0.021" 74 —0.060 0.036
° Four subjects in 3rd and 10th age decades are not shown, but they are included in the total group.
b P < 0.05.
P < 0.01.
P < 0.001.
op < 0.0001.
10
RC — 0.0765
P<0.001
r 0.32
(0>.
.E. 8
6
4o>- 2
a)C
0Q)
a)
- 20,0)
—4
'5 a)
-6'
-8
RC —0.0597
P >0.05
r - 0.19
90 95 100 105 110 115 120 125 130
Mean blood pressure, mm Hg
Fig. 2. Regression coefficients (RC) plotting decline in renal junction
(change in c'reatinine clearance vs. time in years or Bcr) against mean
blood pressute (MBP): Category 2. 74 subjects treated with diuretic
and/or antihypertensive agents.
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Table 5. Regression coefficients (B) SE of the estimates (SEEt) using B. as the dependent variable and MBP as the independent variable by
category when MBP above 120, 114, and 107 mm Hg are stepwise eliminated from analysis
.MBP limits
mm Hg
All subjects Category 1 Category 2 Category 3
No.
——_B SEESt
No. B SEES No. B SEESt No. B SEES
MBP < 120 430 —0.060 0.Olla 113 —0.077 0.024b 66 —0.101 0.045w 251 —0.054 0.014"
MBP < 114 400 —0.048 0.013b 104 —0.075 0.028" 54 —0.090 0.066 242 —0.024 0.015"
MBP < 107 356 —0.023 0.016 88 —0.047 0.036 41 —0.051 0.111 227 —0.022 0.017
"P < 0.0001.
"P < 0.01.
P < 0.05.
70 75 80 85 90 95 100 105 110 115 120 125 130
Mean blood pressure, mm Hg
Fig. 3. Regression coefficients (RC) plotting decline in renal function(change in creatinine clearance vs. time in years or B) against mean
blood pressure (MBP): Category 3, 254 ' normal'' subjects.
the negative correlation between Bcr, and MBP is seen primar-
ily because of the impact produced by individuals with hyper-
tension.
The medical records of the 22 subjects in category 3 with
hypertension (MBP > 107 mm Hg) and decreases in renal
function (negative Bc) were reviewed to eliminate the possibil-
ity that underlying disease or associated therapies might have
been responsible for the accelerated decline in renal function
observed in hypertensive subjects. There were two subjects
with compensated congestive heart failure on digitalis prepara-
tions and two subjects with adult onset diabetes mellitus on oral
hypoglycemics (tolbutamide) in this group: no other pathology
or medications were identified which may have affected the
creatinine clearances.
Simple linear regression analysis of B. as the dependent
variable and BMBP as the independent variable
An additional hypothesis tested was that when the slope
(regression coefficient) of the MBP (BMBp) increases more
rapidly over time (years), the rate of decline in creatinine with
time (years) also is more rapid. When one compares the
regression coefficient of creatinine clearance plotted against
time in years (Br) as the dependent variable against the slope
of the mean blood pressure plotted against time in years (BMBp)
as the independent variable, the inverse relationship does not
reach levels of statistical significance. When one includes all
subjects, the Bcr versus the BMBP is —0.055 (F value 0.33, P =
NS).
When one looks at only category 3 subjects, however, the Bc.
versus BMBP is —0.24 (F value 5.3, P < 0.05). Within this
category, the 61 subjects in the 50-year-old age decade had a
slope of —0.45 (F value 7.6, P < 0.01) and the 46 subjects in the
60-year-old age decade had a slope of —0.75 (F value 6.3, P <
0.05). These data suggest that in the "normal" subjects, those
with more rapidly increasing MBP over time had a more rapid
decline in renal function with age.
Correlations of Bc1 with systolic, diastolic and mean blood
pressures
One of the assumptions made initially was that the MBP
would be the most appropriate single determination of BP to
utilize in this analysis. More significant negative correlations
were observed between Br versus BP when systolic pressure
was substituted for MBP; less significant negative correlations
were observed between Bc, versus BP when diastolic pressure
was substituted for MBP. Since systolic blood pressures in-
creased more with age than diastolic blood pressures, this is
very likely an age-related phenomenon.
Discussion
The purpose of this study was to demonstrate, using longitu-
dinal observations, that the rate of decline in renal function over
time (years) is correlated with BP. The mean blood pressure
(MBP) was selected as the measure of BP to be utilized in this
study, however, the computer programs provided nearly identi-
cal analyses for diastolic and systolic pressures alone for
comparison. After simple linear regression equations were
calculated for each subject plotting creatinine clearances
against time in years to obtain a slope or regression coefficient
(Bc,), similar regression equations were obtained by plotting all
individual slopes against MBP. The negative regression co-
efficients were highly significant for all subjects and for subjects
in categories I and 3. Although the Bc, decreases with age and
MBP increases with age making it appear that this negative
correlation might he explained by differences in the ages of
subjects alone, significant negative correlations also existed in
three of the four age decades with sufficient numbers of subjects
to analyze statistically. Furthermore, when one utilizes a mul-
tiple regression analysis, using both MBP and age as indepen-
dent variables and Bc, as the dependent variable, both MBP and
age exert significant effects on Br. When one stepwise ex-
cludes the moderately severe and then the mildly hypertensive
subjects, much of the negative correlation between MBP and
Bc,. is lost. Finally, when all subjects with a MBP above 107 mm
Hg (equivalent to 140/90 mm Hg) are eliminated, essentially no
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Table 6. Multiple regression and correlation analysis to determine relative effects of MBP and age on B. in all subjects and category 3
(normal) subjects when MBP above 120, 114, and 107 mm Hg are stepwise eliminated from the analysis
Model (Bc, = a + b MBP cAge) All subjects MBP < 120mm Hg MBP < 114mm Hg MBP < 107 mm Hg
All subjects
Number 446 430 400 356
Bcr, cc/mm/mm Hg —0.874 —0.854 —0.737 —0.575
Y intercept (a) 5.275° 5.935° 4.878" 2.580
Partial regression coefficients
MBP (b) —0.014
Age (c) —0.035° —0.037" —0.032"
Correlation coefficients (r) 0.31" 033" 0.29a 0.22°
F values
Model 24.0° 26.2" l8.la 91a
MBP 28.6a 30.7" 14.5" 2.3
Age 19.5" 21.6" 21.7" 16.0"
Category 3 subjects
Number 254 251 242 227
Bcr, cc/mm/mm Hg —0.754 —0.758 —0.683 —0.584
Y intercept (a) 4.114 4.710" 3.980 2.308
Partial Regression Coefficients
MBP (b) —0.026 —0.009
Age (c) —0.038" —0.039" —0.039" —0.037'
Correlation Coefficients (r) Ø34b 0.36" 0.32" —0.27"
F values
Model 15.9" 18.2" 13.3° 9.0"
MBP 14.4" 17.0" 79b 1.7
Age 17.4' 19.3" 18.7a 16.3a
a JJ < 0.0001.
P < 0.01.
"P < 0.001.
d P < 0.05.
negative correlation remains. This suggests the negative cor-
relation between MBP and Br is largely related to an acceler-
ated loss of renal function observed in mild to moderately
severe hypertensive subjects.
Concern first must be generated over whether or not the
creatinine clearance determination is a valid methodology for
following renal function serially. The renal clearance of inulin
meets the requirements for an ideal method to measure GFR
and is the standard against which other methods are compared.
Because determination of inulin clearance rates requires infu-
sion of an expensive material and is a technically difficult
chemical analysis, the endogenous creatinine clearance rate has
been accepted as a substitute for clinical quantification of renal
function [41. The true creatinine clearances used in this study
are more precise but less accurate (compared against inulin
clearances) than are the creatinine clearances obtained using
total chromagen methodology (autoanalyzer). Healy [11] found
a correlation coefficient for the true creatinine versus inulin
clearance of 0.956 compared to a correlation coefficient of 0.864
for the total chromagen versus inulin clearance. For purposes of
following serial changes in renal function over time, the true
creatinine clearance measurements appear superior to the use
of total chromagen methodology. Rowe et al [41 showed that the
renal handling of creatinine relative to inulin does not change
with age so that the age-related decline in crealinine clearance
cannot be attributed to any decrease in renal tubular secretion
of creatinine in older subjects. There were no changes in
creatinine methodology during the period of study reported
herein.
All subjects with a history of potential underlying renal
and/or urinary tract disease which might have initiated or
increased hypertension along with a greater decline in renal
function over time were separated into a diagnostic category
apart from the "normal" subjects. After completion of the
analysis, this appears unnecessary for all but a small select
group of eight subjects with identifiable renal lesions and rapid
declines in renal function. Furthermore, elimination of subjects
treated with diuretics and/or antihypertensive agents (category
2) had no significant effect on the results. Nevertheless, cat-
egory 3 subjects represent a 'normal" or "clinically clean"
group of subjects which were identified to avoid potential bias
from underlying renal or other pathology. The most likely
explanation for the decrease in creatinine clearance both with
age and in hypertensive subjects is the development of
microvascular disease. Normally, arterioles show little age
change with mild hyalinization being the only lesion observed
[12, 131. The changes of arteriolar nephrosclerosis, specifically
intimal proliferation, medial hypertrophy, and necrosis are rare
in the absence of hypertension. Approximately 15% of
normotensive individuals over the age of 50 years have such
lesions, whereas arteriolar changes are present in most, but not
all, kidneys when hypertension is present for many years [12,
14, 151. In summary, although we are able to establish an
inverse relationship between BP and the rate of decline in renal
function, we are left unable to draw any conclusions from these
data as to whether renal microvascular or parenchymal pathol-
ogy is the cause of the hypertension or the hypertension is the
868 Lindeman et a!
etiology of the accelerated decline in renal function observed
over time.
Reprint requests to Dr. R. D. Lindetnan, Veterans Administration
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